Directed-substitution sequences developed from peptides 44 and 46
. | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . | P7 . | P8 . | P9 . | . | . | . | . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Substitutions4-150 . | . | . | . | . | . | . | V . | . | . | . | . | . | . |
. | Y . | . | L . | . | . | . | T . | S . | . | T-cell clones . | |||
. | N . | L . | V . | P . | M . | V . | A . | T . | V . | 3-3F4 . | VB57 . | ||
Peptide name . | . | . | . | . | . | . | . | . | . | −NH2 . | −COOH . | −NH2 . | −COOH . |
193 | Y | L | V | P | M | V | A | T | V | 0.0054-151 | > 5 | 0.05 | > 5 |
194 | N | L | L | P | M | V | A | T | V | 0.05 | > 5 | 0.5 | > 5 |
110 | N | L | V | P | M | V | V | T | V | 0.05 | 0.5 | > 5 | ND |
111 | N | L | V | P | M | V | T | T | V | 0.05 | 0.05 | > 5 | 5 |
112 | N | L | V | P | M | V | A | S | V | 0.5 | 5 | 0.5 | 0.5 |
116 | N | L | L | P | M | V | V | T | V | 0.5 | > 5 | > 5 | ND |
117 | N | L | L | P | M | V | T | T | V | 0.05 | 0.5 | > 5 | 5 |
118 | N | L | L | P | M | V | A | S | V | 0.05 | > 5 | 0.05 | > 5 |
119 | N | L | V | P | M | V | V | S | V | 0.005 | > 5 | > 5 | > 5 |
120 | N | L | V | P | M | V | T | S | V | 0.05 | 5 | > 5 | > 5 |
195 | Y | L | L | P | M | V | A | T | V | 0.005 | > 5 | 0.5 | > 5 |
113 | Y | L | V | P | M | V | V | T | V | 0.5 | > 5 | > 5 | ND |
114 | Y | L | V | P | M | V | T | T | V | 0.05 | 0.5 | 5 | 5 |
115 | Y | L | V | P | M | V | A | S | V | 0.005 | > 5 | 0.05 | 5 |
126 | N | L | L | P | M | V | V | S | V | 0.005 | 5 | 0.5 | > 5 |
127 | N | L | L | P | M | V | T | S | V | 0.05 | 5 | > 5 | > 5 |
124 | Y | L | V | P | M | V | V | S | V | 0.5 | > 5 | 5 | > 5 |
125 | Y | L | V | P | M | V | T | S | V | 0.05 | > 5 | > 5 | > 5 |
121 | Y | L | L | P | M | V | V | T | V | 5 | > 5 | > 5 | ND |
122 | Y | L | L | P | M | V | T | T | V | 5 | > 5 | > 5 | > 5 |
123 | Y | L | L | P | M | V | A | S | V | 0.05 | > 5 | 0.5 | > 5 |
. | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . | P7 . | P8 . | P9 . | . | . | . | . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Substitutions4-150 . | . | . | . | . | . | . | V . | . | . | . | . | . | . |
. | Y . | . | L . | . | . | . | T . | S . | . | T-cell clones . | |||
. | N . | L . | V . | P . | M . | V . | A . | T . | V . | 3-3F4 . | VB57 . | ||
Peptide name . | . | . | . | . | . | . | . | . | . | −NH2 . | −COOH . | −NH2 . | −COOH . |
193 | Y | L | V | P | M | V | A | T | V | 0.0054-151 | > 5 | 0.05 | > 5 |
194 | N | L | L | P | M | V | A | T | V | 0.05 | > 5 | 0.5 | > 5 |
110 | N | L | V | P | M | V | V | T | V | 0.05 | 0.5 | > 5 | ND |
111 | N | L | V | P | M | V | T | T | V | 0.05 | 0.05 | > 5 | 5 |
112 | N | L | V | P | M | V | A | S | V | 0.5 | 5 | 0.5 | 0.5 |
116 | N | L | L | P | M | V | V | T | V | 0.5 | > 5 | > 5 | ND |
117 | N | L | L | P | M | V | T | T | V | 0.05 | 0.5 | > 5 | 5 |
118 | N | L | L | P | M | V | A | S | V | 0.05 | > 5 | 0.05 | > 5 |
119 | N | L | V | P | M | V | V | S | V | 0.005 | > 5 | > 5 | > 5 |
120 | N | L | V | P | M | V | T | S | V | 0.05 | 5 | > 5 | > 5 |
195 | Y | L | L | P | M | V | A | T | V | 0.005 | > 5 | 0.5 | > 5 |
113 | Y | L | V | P | M | V | V | T | V | 0.5 | > 5 | > 5 | ND |
114 | Y | L | V | P | M | V | T | T | V | 0.05 | 0.5 | 5 | 5 |
115 | Y | L | V | P | M | V | A | S | V | 0.005 | > 5 | 0.05 | 5 |
126 | N | L | L | P | M | V | V | S | V | 0.005 | 5 | 0.5 | > 5 |
127 | N | L | L | P | M | V | T | S | V | 0.05 | 5 | > 5 | > 5 |
124 | Y | L | V | P | M | V | V | S | V | 0.5 | > 5 | 5 | > 5 |
125 | Y | L | V | P | M | V | T | S | V | 0.05 | > 5 | > 5 | > 5 |
121 | Y | L | L | P | M | V | V | T | V | 5 | > 5 | > 5 | ND |
122 | Y | L | L | P | M | V | T | T | V | 5 | > 5 | > 5 | > 5 |
123 | Y | L | L | P | M | V | A | S | V | 0.05 | > 5 | 0.5 | > 5 |
ND indicates not determined; TCC, T-cell clone.
The substitutions at each position are shown above the peptide sequences; this is given for positions that were varied in the library screen (Table 3) (ie, P1, P3, P7, and P8). Each peptide was made either with an amidated (NH2) or free-acid (COOH) terminus.
The concentration of peptide is that in which specific killing was between 15% and 30%. Peptides were tested using 10-fold dilutions between 500 and 0.00005 (3-3F4) or 0.005 (VB57) nM. The best peptides for each TCC and terminus are bolded.